Table 1.
Baseline characteristics of patients completing the study a
| Characteristic (unit) | G-CSF group (n = 50) | Control group (n = 49) |
|---|---|---|
| Age (years) | 36.6 ± 3.8 | 37.5 ± 3.5 |
| Infertility duration (years) | 2.3 ± 2.1 | 2.4 ± 3.1 |
| Number of previous ART attempts | 0.3 ± 0.8 | 0.2 ± 0.4 |
| Gravidity | 0.8 ± 0.8 | 1.0 ± 1.1 |
| Parity | 0.5 ± 0.6 | 0.4 ± 0.6 |
| Body mass index (kg/m2) | 20.9 ± 2.3 | 21.1 ± 2.8 |
| Anti-Müllerian hormone (AMH, ng/mL) | 0.98 ± 0.54 | 0.91 ± 0.49 |
| Follicle-stimulating hormone on day 3 (IU/L) | 9.2 ± 6.4 | 8.6 ± 4.7 |
| Luteinizing hormone on day 3 (IU/L) | 4.3 ± 2.7 | 4.0 ± 1.8 |
| Prolactin (ng/mL) | 7.3 ± 3.5 | 8.8 ± 6.1 |
| Estradiol on day 3 (pg/mL) | 32 ± 16 | 41 ± 28 |
| Free testosterone on day 3 (FT, pg/mL) b | 0.60 ± 0.02, n = 24 | 0.60 ± 0.00, n = 25 |
| Testosterone on day 3 (T, ng/mL) b | 0.16 ± 0.08, n = 26 | 0.17 ± 0.08, n = 24 |
| Thyroid-stimulating hormone (TSH, μIU/mL) | 1.88 ± 1.07 c | 2.46 ± 1.40 |
| Free thyronine (pg/mL) | 2.92 ± 0.32 | 2.84 ± 0.43 |
| Free thyroxine (FT4, ng/dL) | 1.23 ± 0.14 | 1.23 ± 0.13 |
| Fasting plasma glucose (mg/dL) | 81.9 ± 6.7, n = 49 | 82.9 ± 6.7, n = 47 |
| Fasting serum insulin (μU/mL) | 4.3 ± 1.9, n = 49 | 4.7 ± 2.0, n = 47 |
a No significant differences were found between groups, except for TSH (unpaired t test for T, FT4, and AMH; Mann–Whitney U test for other characteristics)
b FT and T were measured in the first and second half of this study respectively because production of FT measurement kits was interrupted
cP < 0.05 vs. control group, Mann–Whitney U test